Show simple item record

Analysis of symptoms and functional HRQoL scales in TAGS, a phase III trial of trifluridine/tipiracil (FTD/TPI) in metastatic gastric cancer (mGC)

dc.contributor.authorAlsina, M
dc.contributor.authorTabernero, J
dc.contributor.authorShitara, K
dc.contributor.authorDoi, T
dc.contributor.authorDvorkin, M
dc.contributor.authorMansoor, Was
dc.contributor.authorArkenau, HT
dc.contributor.authorProkharau, A
dc.contributor.authorGhidini, M
dc.contributor.authorFaustino, C
dc.contributor.authorGorbunova, V
dc.contributor.authorZhavrid, E
dc.contributor.authorNishikawa, K
dc.contributor.authorAndo, T
dc.contributor.authorYalcin, S
dc.contributor.authorVan Cutsem, E
dc.contributor.authorSkanji, D
dc.contributor.authorLeger, C
dc.contributor.authorSabater, J
dc.contributor.authorIlson, DH
dc.date.accessioned2019-11-19T16:01:03Z
dc.date.available2019-11-19T16:01:03Z
dc.date.issued2019en
dc.identifier.citationAlsina M, Tabernero J, Shitara K, Doi T, Dvorkin M, Mansoor W, et al. Analysis of symptoms and functional HRQoL scales in TAGS, a phase III trial of trifluridine/tipiracil (FTD/TPI) in metastatic gastric cancer (mGC). J Clin Oncol. 2019;37(15_suppl):4043-.en
dc.identifier.doi10.1200/JCO.2019.37.15_suppl.4043en
dc.identifier.urihttp://hdl.handle.net/10541/622434
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1200/JCO.2019.37.15_suppl.4043en
dc.titleAnalysis of symptoms and functional HRQoL scales in TAGS, a phase III trial of trifluridine/tipiracil (FTD/TPI) in metastatic gastric cancer (mGC)en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentVall d'Hebron Institute of Oncology, Barcelona, Spainen
dc.identifier.journalJournal of Clinical Oncologyen


This item appears in the following Collection(s)

Show simple item record